Astec LifeSciences Q4 FY26 Results Preview & Outlook

Wed Mar 25 2026

Astec LifeSciences latest news: Astec LifeSciences Q4 FY26 results date is all set to be announced soon and most investors are awaiting it. Professionals are expecting an increase in revenue due to higher sales and a significant rise in PAT. Astec LifeSciences was listed on the National Stock Exchange (NSE) on 25-Nov-2009. Astec LifeSciences share has its face value of 10 per share, and its NSE symbol is ASTEC. The company operates in the Chemicals sector and primarily belongs to the Agrochemicals industry.

Table of Contents

Astec LifeSciences Q4 Results 2026 Preview

Astec LifeSciences Q4 FY26 revenue is expected to be around Moderate Growth Expected, representing a 11-15% YoY increase compared to the same quarter last year.
Profit After Tax, or PAT, is projected to rise 13-18% YoY.
EBITDA to rise 15%.
Astec LifeSciences is expected to show Moderate Growth Expected in its revenue.

Click and Sign Up to Get Live Updates on Q4 Results

Astec LifeSciences Share Performance

Over the past six months, Astec LifeSciences share price has Up by 14-20% to 605.3.
Moreover, over the past year, the stock has Up by 28%
Despite this weak short-term performance, Astec LifeSciences stock has delivered a financially sound 190% return over the past 5 years.
As of today, 25-03-2026, the Astec LifeSciences share price is trading at 605.3 per share.

Key Factors to Watch for Astec LifeSciences Q4 Results FY26

Revenue Growth & Segment Performance – Focus on topline growth in the Agrochemicals industry within the Chemicals sector.
Occupancy Levels & Seat Expansion – Monitor operational expansion and capacity utilisation trends.
Profitability & Margin Trends – Track EBITDA and PAT margins to evaluate cost control and operating efficiency.
Order Book & New Client Wins – Watch for updates on new contracts, partnerships, and long-term deals.
Balance Sheet & Cash Flow Position – Review debt levels, working capital management, and operating cash flows for financial stability.

Visit Univest app or website to check more Astec LifeSciences latest news to make an informed investment decision.

About Astec LifeSciences

Astec LifeSciences manufactures agrochemical active ingredients and intermediates for global markets. The company focuses on R&D-driven growth and benefits from rising demand in crop protection and agricultural productivity.

Visit Univest app or website to check more Astec LifeSciences latest news to make an informed investment decision.

Final Thoughts

Astec LifeSciences is gear up to announce its Q4 FY26 results. Analysts expect 11-15% revenue growth, a 13-18% rise in PAT, and a 15% rise in EBITDA. Astec LifeSciences focuses on revenue growth from order execution, margin improvement, a strong order book, and management.

Stay informed with Univest blogs to get real-time updates on Astec LifeSciences Q4 results FY26.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.